Pharmafile Logo
Pharmafocus logo
Advanced Search

Evotec wins grant to advance H3 receptor antagonist

May 4, 2010
Research and Development CNS, Evotec, MS

Evotec is to receive funding of up to 1.5 million euros from a German government fund to advance its H3 …

News
Enlacamacomonunca.com

Digital Pharma: Bayer expands InBed ED campaign

April 30, 2010
Medical Communications Bayer Schering Pharma, digital pharma, disease awareness campaigns, erectile dysfunction

Bayer Schering Pharma has launched a Spanish version of its InBed erectile dysfunction disease awareness campaign. Under the tagline ‘en la …

News

Colorcon buys French excipients specialist

April 30, 2010
Manufacturing and Production Colorcon, Ethypharm, NP Pharm, contract manufacturing, excipients

US-based Colorcon has acquired excipient specialist NP Pharm, a division of French drugmaker Ethypharm, in order to expand its product portfolio …

News

Shire revenue dips after generic Adderall hit

April 30, 2010
Sales and Marketing Adderall, Fabrazyme, Gaucher's, Shire

Shire’s first quarter revenues fell by 5% after its ADHD treatment Adderall XR succumbed to generic competition from Teva.  This …

News

FDA warns Teva over California plant

April 30, 2010
Manufacturing and Production Teva, manufacturing compliance

Teva has become the latest drugmaker to be rebuked by the FDA for not responding effectively enough to compliance problems …

News

Plavix boosts BMS first quarter figures

April 30, 2010
Sales and Marketing BMS, Plavix

Plavix has boosted Bristol-Myers Squibb’s performance in the first quarter of the year, with sales of the anti-clotting blockbuster up …

News
Frazier

Merck separates president role, appoints Kenneth Frazier

April 30, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Merck & Co, appointment, manufacturing and production, research and development, sales and marketing

Merck & Co has partially split the joint roles of chairman, chief executive and president currently held by Richard Clark, …

Appointment

Victoza claims head-to-head victory over Januvia

April 29, 2010
Research and Development, Sales and Marketing Novo, Novo Nordisk, Victoza

Novo Nordisk says its diabetes treatment showed “significant” benefits over Merck’s rival Januvia in a head-to-head trial. Results published in …

News

Investors get green light to continue Merck lawsuit

April 29, 2010
Merck, Vioxx

Investors suing Merck over ‘omissions and misstatements’ relating to its arthritis pain drug Vioxx will be allowed to continue with …

News

CME Spotlight: De-coding the letter of the law

April 29, 2010
Medical Communications CME, CME Spotlight

Legal systems can raise interesting philosophical points sometimes.At the time of writing, the UK is in the throws of a …

Feature

Doctors.net.uk reports record year for online interaction with doctors

April 29, 2010
Medical Communications CME, doctors.net, social networking

Online doctors’ community Doctors.net.uk says it saw record levels of doctor engagement in 2009, with 25 million unique web sessions during …

News

US pharma execs join Algeta board

April 29, 2010
Research and Development Algeta, appointment, research and development

Oslo-based oncology company Algeta has added Judith Hemberger and Kapil Dhingra to its board of directors. Judith Hemberger has more …

Appointment

RNA Interference using nanoparticles hits target in human patients

April 29, 2010
Research and Development SiRNA, nanoparticles, rnai

US researchers have shown that a targeted nanoparticle can penetrate cancer cells in order to deliver small interfering RNAs (siRNAs), …

News

Asia and emerging markets boost GSK results

April 28, 2010
Sales and Marketing GSK

Asia and emerging markets boost GlaxoSmithKline results GlaxoSmithKline has seen a jump in pharma sales due to major growth in …

News

Merck bounces back

April 28, 2010
Sales and Marketing Merck KGaA

Merck KgaA tripled its profit year-on-year in the first quarter of 2010, largely on the back of a better than …

News

Obituary – Tony Forbes-Leith

April 28, 2010
Business Services appointment, business services, rsa

RSA director Tony Forbes-Leith passed away last month after a long and serious illness. He officially joined the company in …

Appointment

AstraZeneca settles Seroquel marketing charges

April 28, 2010
Sales and Marketing Seroquel

AstraZeneca has agreed to pay $520 million to settle US federal investigations into the marketing of its antipsychotic blockbuster Seroquel. …

News
Robert_Bradway

Amgen promotes Robert Bradway to president

April 28, 2010
Manufacturing and Production, Sales and Marketing Amgen, appointment, manufacturing and production, sales and marketing

Robert Bradway has been appointed president and chief operating officer at US biotech Amgen. Bradway, currently executive VP and chief …

Appointment

GE Healthcare and Nycomed in Russian joint venture

April 27, 2010
Sales and Marketing GE Healthcare, Nycomed

GE Healthcare and Nycomed have formed a joint venture to market and distribute GE Healthcare’s medical diagnostic contrast agents in …

News
Crestor

Crestor gains prevention licence in Europe

April 27, 2010
Sales and Marketing AstraZeneca, Crestor, statin

AstraZeneca’s statin treatment Crestor has been approved in the European Union for the prevention of major cardiovascular events in patients …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025